Supplements slow disease progression during late stage of “dry” age-related macular degeneration
On Jul. 16, 2024, researchers at the National Institutes of Health (NIH) reported they have found that taking…
On Jul. 16, 2024, researchers at the National Institutes of Health (NIH) reported they have found that taking…
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
On Jul. 3, 2024, Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) has approved Dupixent® (dupilumab)…
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
On Jul. 2, 2024, the World Health Organization (WHO) recommended a comprehensive set of tobacco cessation interventions, including…
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Jun. 27, 2024, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert…
On Jun. 26, 2024, National Institute of Allergy and Infectious Diseases (NIAID) announced that research has led to…
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
On Jun. 26, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated its recommendation for the…
On Jun. 25, 2024, Merck Animal Health announced U.S. Department of Agriculture (USDA) approval of NOBIVAC® NXT Canine…
On Jun. 25, 2024, Evotec announced that its Seattle-based subsidiary, Just – Evotec Biologics, was selected by the…
On Jun. 25, 2024 the Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN)…
On Jun. 20, 2024, the U.S. Food and Drug Administration expanded the approval of Sarepta Therapeutics’ Elevidys (delandistrogene…
On Jun. 19, 2024, the Institute for Health Metrics and Evaluation (IHME) released a comprehensive new report that…
On Jun. 17, 2024, Merck announced that the U.S. Food and Drug Administration (FDA) had approved CAPVAXIVE™ (Pneumococcal…
On Jun. 14, 2024, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend…
On Jun. 13, 2024, BioMADE announced an investment in a state-of-the-art bioindustrial manufacturing infrastructure in Minnesota, following support…
On Jun. 11, 2024, the National Academies of Sciences, Engineering, and Medicine released a new report that stated the…
On May 31, 2024, a national research coalition led by the University of British Columbia (UBC) announced a…
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345),…
On May 30, 2024, the World Health Organization (WHO) reported that as of 30 April 2024, over 7.6…
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
On May 30, 2024, Biogen announced that the European Commission (EC) had granted marketing authorization under exceptional circumstances…
On May 29, 2024, 23andMe with support from The Michael J. Fox Foundation for Parkinson’s Research, announced it…
On May 23, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that 109 people from…
Asian American and Pacific Islander History Month celebrates the scientific accomplishments of several firsts, from the first chemo…
On May 10, 2024, the National Academies of Sciences, Engineering, and Medicine reported that the COVID-19 vaccines made…
On May 1, 2024, researchers at the National Institutes of Health (NIH) announced a review in JAMA that…
On Apr. 29, 2024, Oregon Health Sciences University (OHSU) reported a patient with the first documented case of…